Kheiron Medical Technologies

Essential solution

Kheiron's first solution is our award winning AI breast screening solution, Mia™. Mia™ offers a simple case-wise suggestion aligned to the actual critical clinical decision a radiologist has to make: to recall or not to recall a woman for further evaluation. Mia™ has already received CE marking, having demonstrated state-of-the-art performance in an independent, multi-center clinical study in Europe.

The results indicate that Mia™ exceeds the recommended US performance benchmarks for breast screening radiologists. Kheiron Medical Technologies has been awarded multiple grants to support advanced clinical trials of Mia and live deployments across the NHS in England and in Scotland in early 2020. In the US, we are conducting pre-commercial pilots and clinical studies of Mia™ with world leading academic medical centers and independent diagnostic imaging providers.

Date of establishment:2016/1/1

Capital amount: 

Fundraising round:A round

Website address

Company introduction


Detailed solution introduction

Diagnosing cancer is an extremely challenging and time-consuming task, even for the most experienced…


Contact information

Contact person:Helen MacBain

Contact phone:


Team member

Peter Kecskemethy

CEO and co-founder

  • University of Oxford, DPhil LSI DTC - computational statistics
  • Co-founder of 2 previous companies.

Tobias Rijken

CTO and co-founder

  • University College London - MSc computational statistics and machine learning.
  • Head of data science and co-founder - 42 Education.

Sarah Kerruish

Chief Strategy Officer

  • 20 years in Silicon Valley at start-ups.

Alex Hamlow

Chief Commercial Officer

  • Over 20 years in commercial at GE Healthcare

Startup teams

aetherAI, CO., LTD

Digital Pathology Workflow System and AI-Powered Diagnostic Support

AI Explore

Super fast AI HPC platform for smart healthcare

FaceHeart Inc.

Technology Supplier.